We are live on ! Find out more
ICP

Interchange Capital Partners Portfolio holdings

AUM $532M
1-Year Est. Return 26.57%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+26.57%
3 Year Est. Return
+79.59%
5 Year Est. Return
+78.72%
10 Year Est. Return
AUM
$277M
AUM Growth
-$7.16M
Cap. Flow
-$10.5M
Cap. Flow %
-3.79%
Top 10 Hldgs %
26.28%
Holding
306
New
23
Increased
63
Reduced
164
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 16.09%
2 Financials 7.45%
3 Healthcare 6.97%
4 Consumer Discretionary 6.88%
5 Communication Services 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
226
Alibaba
BABA
$276B
$224K 0.08%
2,647
-630
-19% -$59.5K
MET icon
227
MetLife
MET
$62.7B
$224K 0.08%
+2,734
New +$227K
BITX icon
228
CALL
2x Bitcoin ETF
BITX
$899M
$223K 0.08%
+4,300
New +$198K
CL icon
229
Colgate-Palmolive
CL
$74.2B
$217K 0.08%
2,383
+8
+0.3% +$763
VXF icon
230
Vanguard Extended Market ETF
VXF
$30.5B
$216K 0.08%
1,140
-4
-0.3% -$771
GD icon
231
General Dynamics
GD
$106B
$215K 0.08%
819
+78
+11% +$22.5K
ITB icon
232
iShares US Home Construction ETF
ITB
$2.41B
$215K 0.08%
2,075
+431
+26% +$51.1K
TEM
233
Tempus AI
TEM
$7.72B
$214K 0.08%
+6,567
New +$325K
OTIS icon
234
Otis Worldwide
OTIS
$28B
$210K 0.08%
2,267
APH icon
235
Amphenol
APH
$177B
$208K 0.08%
3,001
-447
-13% -$31.3K
IGV icon
236
iShares Expanded Tech-Software Sector ETF
IGV
$12.3B
$208K 0.08%
+2,076
New +$206K
HON icon
237
Honeywell
HON
$78.3B
$206K 0.07%
+968
New +$202K
MCHI icon
238
iShares MSCI China ETF
MCHI
$6.16B
$206K 0.07%
4,390
-1,232
-22% -$60.8K
RXRX icon
239
Recursion Pharmaceuticals
RXRX
$1.62B
$202K 0.07%
30,823
-4,664
-13% -$31.4K
NVS icon
240
Novartis
NVS
$304B
$202K 0.07%
2,074
-93
-4% -$9.92K
LOW icon
241
Lowe's Companies
LOW
$122B
$201K 0.07%
815
-234
-22% -$62.5K
VGK icon
242
Vanguard FTSE Europe ETF
VGK
$30.2B
$200K 0.07%
3,159
+85
+3% +$5.67K
SOFI icon
243
SoFi Technologies
SOFI
$21.5B
$189K 0.07%
12,246
-1,636
-12% -$21.3K
TXG icon
244
10x Genomics
TXG
$5.97B
$175K 0.06%
12,637
+14
+0.1% +$221
GILD icon
245
Gilead Sciences
GILD
$167B
$172K 0.06%
1,858
NTLA icon
246
Intellia Therapeutics
NTLA
$1.52B
$163K 0.06%
14,451
-5,833
-29% -$91K
SLV icon
247
iShares Silver Trust
SLV
$27.6B
$160K 0.06%
6,082
-77
-1% -$2.2K
ENB icon
248
Enbridge
ENB
$121B
$156K 0.06%
+3,670
New +$154K
GILD icon
249
CALL
Gilead Sciences
GILD
$167B
$139K 0.05%
1,500
GOOG icon
250
CALL
Alphabet (Google) Class C
GOOG
$4.07T
$114K 0.04%
600
+300
+100% +$53K

Similar funds

Interchange Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Interchange Capital Partners held 306 positions worth $277M, down 2.5% from $284M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Interchange Capital Partners withdrew a net $10.5M in Q4 2024, closing 41 positions and reducing 164 holdings. Its most notable exit was CVS Health, an estimated $861K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Interchange Capital Partners opened a new position in Medicus Pharma worth $3.63M.

  • Interchange Capital Partners's largest Q4 2024 buy was Medicus Pharma: 1,457,165 shares worth $3.63M.
  • Interchange Capital Partners added most to JPMorgan Ultra-Short Municipal Income ETF in Q4 2024, an estimated $2.62M increase.
  • Interchange Capital Partners's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $790K.
  • Interchange Capital Partners fully exited CVS Health in Q4 2024, selling an estimated $861K.
  • Interchange Capital Partners's ten largest holdings make up 26% of its $277M portfolio in Q4 2024.
  • Interchange Capital Partners opened 23 new positions and closed 41 in Q4 2024.
  • Interchange Capital Partners's portfolio value fell 2.5% quarter-over-quarter to $277M.

Based on Interchange Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.